Cargando…

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China

Detalles Bibliográficos
Autores principales:	Weerasuriya, Chathika K., Harris, Rebecca C., McQuaid, C. Finn, Bozzani, Fiammetta, Ruan, Yunzhou, Li, Renzhong, Li, Tao, Rade, Kirankumar, Rao, Raghuram, Ginsberg, Ann M., Gomez, Gabriela B., White, Richard G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887015/ https://www.ncbi.nlm.nih.gov/pubmed/35227254 http://dx.doi.org/10.1186/s12916-022-02306-3

Ejemplares similares

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K, et al.
Publicado: (2021)

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2022)

Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2021)

Cost-effectiveness of routine adolescent vaccination with an M72/AS01(E)-like tuberculosis vaccine in South Africa and India
por: Harris, Rebecca C., et al.
Publicado: (2022)

The potential health and economic impacts of new tuberculosis vaccines under varying delivery strategies in Delhi and Gujarat, India: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

The potential impact of vaccination on tuberculosis burden in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

New tuberculosis vaccines in India: Modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A, et al.
Publicado: (2023)

New tuberculosis vaccines in India: modelling the potential health and economic impacts of adolescent/adult vaccination with M72/AS01(E) and BCG-revaccination
por: Clark, Rebecca A., et al.
Publicado: (2023)

Practical Experiences of Delivering Multidrug-Resistant Tuberculosis Comprehensive Supportive Care Services in China
por: Ruan, Yunzhou, et al.
Publicado: (2021)

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
por: Knight, Gwenan M, et al.
Publicado: (2019)

Epidemiological Characteristics of Rifampicin-Resistant Tuberculosis in Students — China, 2015–2019
por: Su, Wei, et al.
Publicado: (2021)

Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis
por: Jayawardana, Sahan, et al.
Publicado: (2022)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa
por: Bozzani, Fiammetta M., et al.
Publicado: (2020)

Is knowledge retained by healthcare providers after training? A pragmatic evaluation of drug-resistant tuberculosis management in China
por: Wu, Shishi, et al.
Publicado: (2019)

The prevalence of tuberculosis infection in India: A systematic review and meta-analysis
por: Chauhan, Arohi, et al.
Publicado: (2023)

The Impact of COVID-19 Epidemic on Tuberculosis Reports Among Students — Guizhou Province, China, 2020
por: He, Yuying, et al.
Publicado: (2022)

The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
por: Wang, Lixia, et al.
Publicado: (2017)

Development and Application of a Multidrug-Resistant Tuberculosis Case Management System — Yunnan Province, China, 2017–2020
por: Chen, Jinou, et al.
Publicado: (2022)

The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study
por: Dodd, Peter J, et al.
Publicado: (2022)

The impact of COVID-19 on global tuberculosis control
por: Lipman, Marc, et al.
Publicado: (2021)

Estimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa
por: Sumner, Thomas, et al.
Publicado: (2019)

Complexity and evidence in health sector decision-making: lessons from tuberculosis infection prevention in South Africa
por: Perera, Shehani, et al.
Publicado: (2022)

Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries
por: McQuaid, C. Finn, et al.
Publicado: (2022)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

Using system dynamics modelling to estimate the costs of relaxing health system constraints: a case study of tuberculosis prevention and control interventions in South Africa
por: Bozzani, Fiammetta M, et al.
Publicado: (2021)

Improving the quality of modelling evidence used for tuberculosis policy evaluation
por: Menzies, N. A., et al.
Publicado: (2019)

The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Cross-sectional assessment of tuberculosis and HIV prevalence in 13 correctional facilities in Zambia
por: Kagujje, Mary, et al.
Publicado: (2021)

Application of provincial data in mathematical modelling to inform sub-national tuberculosis program decision-making in South Africa
por: Hippner, Piotr, et al.
Publicado: (2019)

The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis
por: Arinaminpathy, Nimalan, et al.
Publicado: (2020)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Modelling the impact of effective private provider engagement on tuberculosis control in urban India
por: Arinaminpathy, Nimalan, et al.
Publicado: (2019)

Engaging with the private healthcare sector for the control of tuberculosis in India: cost and cost-effectiveness
por: Arinaminpathy, Nimalan, et al.
Publicado: (2021)

Cost-effectiveness of tuberculosis infection prevention and control interventions in South African clinics: a model-based economic evaluation informed by complexity science methods
por: Bozzani, Fiammetta Maria, et al.
Publicado: (2023)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

The Threat of Multidrug-resistant Tuberculosis
por: Paul, Rudrajit
Publicado: (2018)

Fistulized multidrug-resistant tuberculosis
por: El Omri, Naoual, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gh7hij6dee2od5opi6n04c9v26